| Afinitor(R) Phase II Trial Results Positive In Patients With Advanced Gastric Cancer After Failure Of One Or More ... (Medical News Today) |
|
|
Data released today show Afinitor® (also known as RAD001, everolimus) halted tumor growth in 55% of patients with advanced gastric cancer, a condition for which there are limited treatment options. In addition, 45% of patients in the study demonstrated some tumor shrinkage1. |